Tumor necrosis factor alpha: a key component of the obesity-diabetes link
- PMID: 7926300
- DOI: 10.2337/diab.43.11.1271
Tumor necrosis factor alpha: a key component of the obesity-diabetes link
Abstract
Recent data have suggested a key role for tumor necrosis factor (TNF)-alpha in the insulin resistance of obesity and non-insulin-dependent diabetes mellitus (NIDDM). TNF-alpha expression is elevated in the adipose tissue of multiple experimental models of obesity. Neutralization of TNF-alpha in one of these models improves insulin sensitivity by increasing the activity of the insulin receptor tyrosine kinase, specifically in muscle and fat tissues. On a cellular level, TNF-alpha is a potent inhibitor of the insulin-stimulated tyrosine phosphorylations on the beta-chain of the insulin receptor and insulin receptor substrate-1, suggesting a defect at or near the tyrosine kinase activity of the insulin receptor. Given the clear link between obesity, insulin resistance, and diabetes, these results strongly suggest that TNF-alpha may play a crucial role in the systemic insulin resistance of NIDDM. This may allow for new treatments of disorders involving resistance to insulin.
Similar articles
-
Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.J Clin Invest. 1994 Oct;94(4):1543-9. doi: 10.1172/JCI117495. J Clin Invest. 1994. PMID: 7523453 Free PMC article.
-
Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus.J Clin Endocrinol Metab. 1998 Mar;83(3):859-62. doi: 10.1210/jcem.83.3.4618. J Clin Endocrinol Metab. 1998. PMID: 9506740
-
Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat.Diabetes. 1995 Nov;44(11):1266-73. doi: 10.2337/diab.44.11.1266. Diabetes. 1995. PMID: 7589822
-
Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes.Trends Endocrinol Metab. 2000 Aug;11(6):212-7. doi: 10.1016/s1043-2760(00)00272-1. Trends Endocrinol Metab. 2000. PMID: 10878750 Review.
-
Pathophysiology of type 2 diabetes.Acta Clin Belg. 2003 Nov-Dec;58(6):335-41. doi: 10.1179/acb.2003.58.6.001. Acta Clin Belg. 2003. PMID: 15068125 Review.
Cited by
-
Sphingolipid metabolism and obesity-induced inflammation.Front Endocrinol (Lausanne). 2013 Jun 4;4:67. doi: 10.3389/fendo.2013.00067. eCollection 2013. Front Endocrinol (Lausanne). 2013. PMID: 23761785 Free PMC article.
-
Influence of tumour necrosis factor alpha on the outcome of ischaemic postconditioning in the presence of obesity and diabetes.Exp Diabetes Res. 2012;2012:502654. doi: 10.1155/2012/502654. Epub 2012 Oct 17. Exp Diabetes Res. 2012. PMID: 23125848 Free PMC article.
-
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages.Am J Cancer Res. 2013;3(1):21-33. Epub 2013 Jan 18. Am J Cancer Res. 2013. PMID: 23359288 Free PMC article.
-
The Effects of Combined Exercise on Health-Related Fitness, Endotoxin, and Immune Function of Postmenopausal Women with Abdominal Obesity.J Immunol Res. 2015;2015:830567. doi: 10.1155/2015/830567. Epub 2015 May 14. J Immunol Res. 2015. PMID: 26075288 Free PMC article.
-
Skeletal Muscle Adiposity and Lung Function Trajectory in the Severe Asthma Research Program.Am J Respir Crit Care Med. 2023 Feb 15;207(4):475-484. doi: 10.1164/rccm.202203-0597OC. Am J Respir Crit Care Med. 2023. PMID: 36194556 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical